GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (NAS:LVTX) » Definitions » 3-Year Revenue Growth Rate

LAVA Therapeutics NV (LAVA Therapeutics NV) 3-Year Revenue Growth Rate : 19.60% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is LAVA Therapeutics NV 3-Year Revenue Growth Rate?

LAVA Therapeutics NV's Revenue per Share for the three months ended in Dec. 2023 was $0.01.

During the past 12 months, LAVA Therapeutics NV's average Revenue per Share Growth Rate was -66.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 19.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 5 years, the highest 3-Year average Revenue per Share Growth Rate of LAVA Therapeutics NV was 19.60% per year. The lowest was 19.60% per year. And the median was 19.60% per year.


Competitive Comparison of LAVA Therapeutics NV's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, LAVA Therapeutics NV's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LAVA Therapeutics NV's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LAVA Therapeutics NV's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where LAVA Therapeutics NV's 3-Year Revenue Growth Rate falls into.



LAVA Therapeutics NV 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


LAVA Therapeutics NV  (NAS:LVTX) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


LAVA Therapeutics NV 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of LAVA Therapeutics NV's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


LAVA Therapeutics NV (LAVA Therapeutics NV) Business Description

Traded in Other Exchanges
Address
Yalelaan 62, Utrecht, UT, NLD, 3584 CM
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.

LAVA Therapeutics NV (LAVA Therapeutics NV) Headlines

From GuruFocus

LAVA Therapeutics Announces the Appointment of Dr. Charles Morris as Chief Medical Officer

By Stock market mentor Stock market mentor 02-06-2023

LAVA Announces Annual Meeting of Shareholders

By sperokesalga sperokesalga 05-30-2023